Senate Finance chair asks Rob Califf for more details around potential accelerated approval reforms

How is the FDA going to reform its accelerated approval pathway once Rob Califf takes over as FDA commissioner? That’s what Senate Finance committee chair Ron Wyden wants to know, and he wants a “prompt response,” according to a letter Wyden sent to Califf on Friday.